EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device

Vijayalakshmi A Senthilkumar, Umme Salma Akbar, Sharmila Rajendrababu

Indian Journal of Ophthalmology · 2025

DOI: 10.4103/ijo.ijo_958_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Vijayalakshmi A Senthilkumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Glaucoma Drainage Implants, Device Removal, Glaucoma, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report the incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device (GDD).

Methods

Of the total 1303 patients who underwent patch-free GDD (703 non-valved GDD and 600 valved GDD) for refractory glaucoma during January 2020–October 2023, we identified five cases of postoperative complications following GDD that required tube or shunt removal.

Results

Median (IQR) age of our study cohorts was 54.5 (8–66) years. The incidence of tube exposure and tube explantation was 0.003% and 0.004%, respectively. The median time interval for tube or plate explantation from the time of GDD surgery was 11.5 (2–16) months. The diagnoses of refractory glaucoma for which GDD was performed were secondary glaucoma following multiple vitreoretinal (VR) surgery (60%), primary open-angle glaucoma (20%), and aphakic glaucoma (20%). Of these, two patients (40%) presented with recurrent tube exposures, two patients (40%) with tube exposure and early endophthalmitis, and one patient (20%) with persistent hypotony. Four patients (80%) had undergone non-valved Aurolab aqueous drainage implant and one underwent (20%) Ahmed glaucoma implant. Three patients (60%) had diabetes mellitus with a history of multiple VR surgical intervention. GDD explantation was done in three patients (60%), and the remaining two patients (40%) required only tube amputation. One patient presented with orbital cellulitis, and there was no culture growth seen in any of our study cohorts.

Conclusion

Tube and plate exposures pose a significant risk for potential infections and warrant prompt explantation of GDD to avoid endophthalmitis. Previous history of multiple VR surgeries, diabetes mellitus, and non-valved implants were the common risk associations noted for tube exposures in our retrospective study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma Drainage ImplantsDevice RemovalGlaucomaPostoperative ComplicationsIntraocular PressureHumansIncidenceMaleRisk FactorsMiddle AgedFemaleAgedRetrospective StudiesAdultChildAdolescentYoung AdultFollow-Up Studies

Autor:innen und Institutionen

  • Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.

Zitieren

APA

Senthilkumar, V. A., Akbar, U. S., & Rajendrababu, S. (2025). Incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_958_24

Vancouver

Senthilkumar VA, Akbar US, Rajendrababu S. Incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device. Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_958_24

BibTeX
@article{Senthilkumar2025,
  author = {Senthilkumar, Vijayalakshmi A and Akbar, Umme Salma and Rajendrababu, Sharmila},
  title = {Incidence, etiology, and risk factors for tube explantation in patients undergoing patch-free glaucoma drainage device},
  journal = {Indian Journal of Ophthalmology},
  year = {2025},
  doi = {10.4103/ijo.ijo_958_24}
}
Kostenlos starten →